Lipigon Pharmaceuticals AB is a pharmaceutical company based in Umeå that specializes in blood lipid research, particularly in the management of high cholesterol. With over fifty years of expertise in lipid studies, the company focuses on innovative research and development aimed at improving and extending the lives of patients affected by high blood fats. Lipigon is committed to advancing treatment options and enhancing the understanding of cholesterol-related health issues.
One of the key offerings of Lipigon Pharmaceuticals is its Lipisense® technology, which is designed to aid in the management of blood lipid levels. The company also provides educational resources related to lipid-related diseases, promoting awareness and understanding of these conditions. Through its research initiatives, Lipigon aims to contribute to the development of effective therapies for patients with high cholesterol, thereby addressing a significant health concern globally.